About Us
Independent Medical Technology Advisory
Angionyx is an independent advisory platform supporting medical device manufacturers and distributors with structured market access, partner identification, and technology sourcing.
The focus is on enabling successful commercialization of differentiated medical technologies across Europe and selected emerging markets..
Who Are We
Angionyx operates at the intersection of medical technology, clinical application, and market execution.
With deep exposure to both manufacturing and distribution environments, the platform bridges strategic gaps between innovative producers and experienced local partners, ensuring realistic market entry and sustainable growth.
Our Mission
To accelerate the adoption of valuable medical technologies by aligning manufacturers with the right distribution partners, clinical environments, and commercialization strategies.
Each engagement is designed to reduce market-entry risk, shorten time to revenue, and support long-term positioning in complex healthcare systems
What We Do
- Market access strategy for medical devices
- Distributor identification & qualification
- Partner matchmaking between manufacturers and local operators
- Go-to-market planning for regulated healthcare environments
- Support across Europe and selected emerging markets
Our Market Entry Framework
01.
Discover
Assessment of the technology, clinical value, regulatory status, and competitive landscape.
02.
Define
Clear definition of target markets, ideal distributor profile, and commercialization objectives
03.
Design
Tailored market entry and partner strategy aligned with product positioning and healthcare realities.
04.
Develop
Engagement with qualified distributors, clinical stakeholders, and decision-makers.
05.
Deploy
Structured introduction of the product through selected partners with defined responsibilities..
06.
Deliver
Ongoing support to ensure execution quality, feedback loops, and sustainable market presence..
Why Choose Us?
Experience rooted exclusively in regulated medical technologies.
Access to vetted partners with proven clinical and commercial expertise..
No generic expansion models — each market treated independently.
Focus on real-world implementation, not theoretical consulting.
Emphasis on sustainable cooperation, not transactional introductions.
Considering Market Entry or Expansion?
Strategic market access and the right local partner can define success or failure in medical technology commercialization.
Angionyx supports structured, risk-aware expansion into complex healthcare markets